Operating Margin of PROVECTUS BIOPHARMACEUTICALS, INC. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
PROVECTUS BIOPHARMACEUTICALS, INC. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2022 to 30 Jun 2025.
  • PROVECTUS BIOPHARMACEUTICALS, INC. Operating Margin for the quarter ending 30 Jun 2025 was -1345%, a 259% decline year-over-year.
  • PROVECTUS BIOPHARMACEUTICALS, INC. annual Operating Margin for 2024 was -734%, a 41% decline from 2023.
  • PROVECTUS BIOPHARMACEUTICALS, INC. annual Operating Margin for 2023 was -520%, a 50% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -1345% -970% -259% 01 Apr 2025 30 Jun 2025
Q1 2025 -788% -354% -81% 01 Jan 2025 31 Mar 2025
Q4 2024 -734% -214% -41% 01 Oct 2024 31 Dec 2024
Q3 2024 -387% +108% +22% 01 Jul 2024 30 Sep 2024
Q2 2024 -374% -28% -8.1% 01 Apr 2024 30 Jun 2024
Q1 2024 -434% -115% -36% 01 Jan 2024 31 Mar 2024
Q4 2023 -520% -174% -50% 01 Oct 2023 31 Dec 2023
Q3 2023 -496% 01 Jul 2023 30 Sep 2023
Q2 2023 -346% 01 Apr 2023 30 Jun 2023
Q1 2023 -319% 01 Jan 2023 31 Mar 2023
Q4 2022 -347% 01 Oct 2022 31 Dec 2022

PROVECTUS BIOPHARMACEUTICALS, INC. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -734% -214% -41% 01 Jan 2024 31 Dec 2024
2023 -520% -174% -50% 01 Jan 2023 31 Dec 2023
2022 -347% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.